Optimal T Cell Activation by Melanoma Cells Depends on a Minimal Level of Antigen Transcription

Journal of Immunology

Volumn 158, Issue 3, 1997, Pages 1238-1245

  Labarriere, Nathalie ^a,b   Diez, Elizabeth ^a   Pandolfino, Marie Christine ^b   Viret, Christophe ^d   Guilloux, Yannik ^e   Le Guiner, Soizic ^a   Fonteneau, Jean Francois ^a   Dreno, Brigitte ^b,c   Jotereau, Francine ^a,f  

^a INSERM   (France)

^b Unit of Cellular Genetic Therapy   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INSTITUT PASTEUR   (France)

^f INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MEMBRANE ANTIGEN; MESSENGER RNA; RNA; TUMOR ANTIGEN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MELANOMA; METABOLISM; T LYMPHOCYTE;

ANTIGENS, CD58; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA-A2 ANTIGEN; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MELANOMA; RNA, MESSENGER; RNA, NEOPLASM; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031065147     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Boon, T., J.-C. Cerottini, B. van den Eynde, P. Van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12: 337.
2. Bluestone, J. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
3. + tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells. in vitro. Eur. J. Immunol. 24:1966.
4. Viret, C., N. Gervois, Y. Guilloux, E. Le Dréan, M. C. Pandolfino, E. Diez, and F. Jotereau. 1995. T cell activation by antigens on human melanoma cells costimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro. Int. Immunol. 7:1535.
5. Gervois, N., Y. Guilloux, E. Diez, and F. Jotereau. 1996. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions. J. Exp. Med. 183:1.
6. Coulie, P. G., V. Brichard, A. Van Pel, T. Wölfel, J. Schneider, C. Traversari, E. De Plaen, C. Lurquin, J. Szikora, J. C. Renauld, and Boon, T. 1994. A new gene coding for a differentiation antigen recognized by autologous cytotytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35.
7. Kawakami, Y., S. Eliyahu, C. H. Delgado, P. F. Robbins, L. Rivoltini, S. L. Topalian, T. Miki, and S. A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumors. Proc. Natl. Acad. Sci. USA 91:3515.
8. Guilloux, Y., S. Lucas, V. Brichard, A. Van Pel, C. Viret, E. De Plaen, F. Brasseur, B. Lethe, F. Jotereau, and T. Boon. 1996. A peptide recognized by cytolytic lymphocytes on HLA-A2 melanomas is encoded by a sequence located in an intron of the human N-acetylglucosaminyltransferase V gene. J. Exp. Med. 183:1173.
9. + T cell clones derived from human melanoma infiltrating lymphocytes (TIL) in response to autologous tumor cells. Ear. J. Immunol. 22:1795.
10. + cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements. Eur. J. Immunol. 20:825.
11. Davis, L. G., M. D. Dibner, and J. F. Battey. 1986. Basic Methods in Molecular Biology. Elsevier, New York.
12. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425.
13. Mosteller, F., and J. W. Tuckey. 1977. Data Analysis and Regression: A Second Course in Statistics. Addison-Wesley, Reading, MA.
14. Conover, W. J. 1980. Practical Nonparametric Statistics. John Wiley and Sons, New York.
15. Valittuti, S., S. Müller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917.
16. Rivoltini, L., K. C. Barrachini, V. Viggiano, Y. Kawakami, A. Smith, A. Mixon, N. P. Restifo, S. L. Topalian, T. B. Simonis, S. A. Rosenberg, and F. M. Marincola. 1995. Quantitative correlation between HLA class I allele expression and recognition of melanoma-specific cytotoxic T lymphocytes. Cancer Res. 55:3149.
17. Davis, S. J., and A. van der Merwe. 1996. The structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today 17:177.
18. Makgoba, M. W., M. E. Sanders, G. E. Ginther Luce, E. A. Gugel, M. L. Dustin, T. A. Springer, and S. Shaw. 1988. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity. Eur. J. Immunol. 118:637.
19. Altomonte, M., A. Gloghini, G. Bertola, A. Gasparollo, A. Carbone, S. Ferrone, and M. Maio. 1993. Differential expression of cell adhesion molecules CD54/ CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res. 53:3343.
20. Van Seventer, G. A., Y. Shimizu, K. J. Horgan, and S. Shaw. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. Eur. J. Immunol. 144:4579.